Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes.

Coxsackievirus B autoimmunity enterovirus fetal and perinatal life self-tolerance thymus type diabetes viruses

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
29 May 2021
Historique:
received: 31 03 2021
revised: 12 05 2021
accepted: 26 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

The thymus gland is a primary lymphoid organ for T-cell development. Various viral infections can result in disturbance of thymic functions. Medullary thymic epithelial cells (mTECs) are important for the negative selection of self-reactive T-cells to ensure central tolerance. Insulin-like growth factor 2 (IGF2) is the dominant self-peptide of the insulin family expressed in mTECs and plays a crucial role in the intra-thymic programing of central tolerance to insulin-secreting islet β-cells. Coxsackievirus B4 (CVB4) can infect and persist in the thymus of humans and mice, thus hampering the T-cell maturation and differentiation process. The modulation of IGF2 expression and protein synthesis during a CVB4 infection has been observed in vitro and in vivo in mouse models. The effect of CVB4 infections on human and mouse fetal thymus has been studied in vitro. Moreover, following the inoculation of CVB4 in pregnant mice, the thymic function in the fetus and offspring was disturbed. A defect in the intra-thymic expression of self-peptides by mTECs may be triggered by CVB4. The effects of viral infections, especially CVB4 infection, on thymic cells and functions and their possible role in the pathogenesis of type 1 diabetes (T1D) are presented.

Identifiants

pubmed: 34072590
pii: microorganisms9061177
doi: 10.3390/microorganisms9061177
pmc: PMC8229779
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Curr Opin Toxicol. 2018 Feb;7:22-27
pubmed: 29532040
J Virol. 1996 Jun;70(6):3734-40
pubmed: 8648708
Clin Exp Immunol. 2012 Apr;168(1):39-46
pubmed: 22385235
J Mol Biol. 2013 Dec 13;425(24):5020-31
pubmed: 24120940
PLoS One. 2017 Oct 19;12(10):e0185761
pubmed: 29049344
Nature. 2006 Jun 22;441(7096):992-6
pubmed: 16791198
Braz J Med Biol Res. 1994 Jul;27(7):1599-603
pubmed: 7874026
Pediatr Endocrinol Rev. 2019 Dec;17(2):78-83
pubmed: 31763800
Semin Pediatr Infect Dis. 2002 Jan;13(1):40-7
pubmed: 12118843
J Infect Dis. 1973 Dec;128(6):795-9
pubmed: 4203079
Microbiol Immunol. 1992;36(12):1277-90
pubmed: 1287404
J Allergy Clin Immunol. 2014 Jun;133(6):1702-8.e5
pubmed: 24698315
Obstet Gynecol. 2001 Dec;98(6):1019-26
pubmed: 11755547
Viruses. 2019 Sep 09;11(9):
pubmed: 31505755
Microb Pathog. 2018 Mar;116:279-288
pubmed: 29325864
Front Immunol. 2020 Apr 02;11:481
pubmed: 32300341
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):104-8
pubmed: 7678330
Front Immunol. 2015 Jun 30;6:338
pubmed: 26175734
J Virol. 2005 Nov;79(22):13882-91
pubmed: 16254324
Annu Rev Immunol. 2006;24:571-606
pubmed: 16551260
Scand J Immunol. 2013 Oct;78(4):378-86
pubmed: 23841696
Sci Rep. 2020 Jan 28;10(1):1378
pubmed: 31992777
Diabetes. 2005 May;54(5):1407-14
pubmed: 15855327
BMC Infect Dis. 2017 Jan 5;17(1):18
pubmed: 28056841
Ann N Y Acad Sci. 2019 Nov;1455(1):113-125
pubmed: 31008523
Immunobiology. 2017 Dec;222(12):1053-1063
pubmed: 28888743
J Biol Chem. 2014 Jun 20;289(25):17941-50
pubmed: 24811165
Diabetes Care. 2001 May;24(5):838-42
pubmed: 11347740
Clin Exp Immunol. 2012 Apr;168(1):47-51
pubmed: 22385236
Front Immunol. 2020 Jan 10;10:3094
pubmed: 31998327
Clin Exp Immunol. 2017 Mar;187(3):399-407
pubmed: 27790717
Curr HIV Res. 2004 Apr;2(2):177-83
pubmed: 15078181
Microorganisms. 2020 Sep 23;8(10):
pubmed: 32977495
Discov Med. 2010 Aug;10(51):151-60
pubmed: 20807476
J Virol. 2012 Oct;86(20):11151-62
pubmed: 22855493
Cell Mol Life Sci. 2013 Nov;70(21):4169-80
pubmed: 23775130
Sci Rep. 2015 Sep 07;5:13864
pubmed: 26343909
Infect Genet Evol. 2013 Mar;14:282-93
pubmed: 23201849
J Clin Lab Immunol. 1995;46(2):49-61
pubmed: 8789128
Nat Rev Immunol. 2011 May 27;11(7):489-95
pubmed: 21617694
Eur J Clin Invest. 2015 Sep;45(9):918-24
pubmed: 26108863
Clin Infect Dis. 2017 May 1;64(9):1191-1197
pubmed: 28158588
J Exp Med. 1977 Jun 1;145(6):1617-22
pubmed: 301176
J Med Virol. 2015 Feb;87(2):240-7
pubmed: 25111164
J Gen Virol. 2017 Oct;98(10):2421-2422
pubmed: 28884666
Front Immunol. 2019 Feb 05;10:25
pubmed: 30804925
J Comp Pathol. 2001 Nov;125(4):233-42
pubmed: 11798240
Microorganisms. 2021 Feb 15;9(2):
pubmed: 33672010
Endocrinology. 2000 Mar;141(3):1209-17
pubmed: 10698198
Clin Exp Immunol. 2016 Jan;183(1):16-29
pubmed: 26102289
Nat Rev Endocrinol. 2010 May;6(5):279-89
pubmed: 20351698
Discov Med. 2014 Nov;18(100):273-82
pubmed: 25425468
Cell Immunol. 2005 Feb;233(2):125-32
pubmed: 15963965
J Infect Dis. 1988 Aug;158(2):433-42
pubmed: 3042879
Immunol Today. 1996 Jul;17(7):312-7
pubmed: 8763816
Nat Med. 1998 Jul;4(7):781-5
pubmed: 9662368
J Immunol. 2006 Apr 15;176(8):4651-7
pubmed: 16585557
J Med Virol. 2008 Apr;80(4):659-66
pubmed: 18297721
Paediatr Drugs. 2004;6(1):1-10
pubmed: 14969566
Virulence. 2016 Jul 3;7(5):527-35
pubmed: 27030584
Adv Clin Exp Med. 2016 Mar-Apr;25(2):369-75
pubmed: 27627572
World J Diabetes. 2020 Jan 15;11(1):13-25
pubmed: 31938470
Diabetes Res Clin Pract. 2019 Nov;157:107868
pubmed: 31560963
J Mol Med (Berl). 2000;78(9):483-94
pubmed: 11140374
Nat Rev Microbiol. 2003 Nov;1(2):151-7
pubmed: 15035044
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4598-603
pubmed: 9114036
J Virol. 2004 Sep;78(18):9854-61
pubmed: 15331720
Nat Immunol. 2001 Nov;2(11):1032-9
pubmed: 11600886
Virol J. 2017 Jan 31;14(1):16
pubmed: 28143615
Clin Infect Dis. 2017 Jan 15;64(2):152-158
pubmed: 27986677
J Immunol Methods. 2000 Apr 3;237(1-2):187-97
pubmed: 10725462
J Virol. 1995 Oct;69(10):6541-7
pubmed: 7666556
Virulence. 2017 Aug 18;8(6):908-923
pubmed: 27792461
Viruses. 2019 Jul 02;11(7):
pubmed: 31269669
J Virol. 1999 Mar;73(3):2212-21
pubmed: 9971804
Viruses. 2015 Nov 24;7(11):6067-79
pubmed: 26610550
Nat Immunol. 2001 Nov;2(11):1025-31
pubmed: 11668341
Genes (Basel). 2020 Mar 05;11(3):
pubmed: 32150956
Asian Pac J Allergy Immunol. 1997 Sep;15(3):127-32
pubmed: 9438544
Virology. 2018 Sep;522:271-280
pubmed: 30056354
J Gen Virol. 2002 Sep;83(Pt 9):2169-2176
pubmed: 12185270
Trends Immunol. 2017 Nov;38(11):805-816
pubmed: 28830733
J Virol. 2002 May;76(10):5260-5
pubmed: 11967339
Curr Opin Infect Dis. 2013 Jun;26(3):263-9
pubmed: 23549392
Microbiol Immunol. 2006;50(12):971-4
pubmed: 17179665
J Virol. 2000 Nov;74(21):10153-64
pubmed: 11024144
Hum Pathol. 2004 May;35(5):536-45
pubmed: 15138926
Front Immunol. 2020 Jan 31;10:3099
pubmed: 32082299
Science. 1993 Jun 25;260(5116):1942-6
pubmed: 8100367

Auteurs

Abdulaziz Alhazmi (A)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.
Microbiology and Parasitology Department, College of Medicine, Jazan University, Jazan 82911, Saudi Arabia.

Magloire Pandoua Nekoua (MP)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.

Hélène Michaux (H)

GIGA-I3 Center of Immunoendocrinology, GIGA Research Institute, University of Liège, 4000 Liège, Belgium.

Famara Sane (F)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.

Aymen Halouani (A)

Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives LR99ES27, Université de Monastir, 5000 Monastir, Tunisia.

Ilka Engelmann (I)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.

Enagnon Kazali Alidjinou (EK)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.

Henri Martens (H)

GIGA-I3 Center of Immunoendocrinology, GIGA Research Institute, University of Liège, 4000 Liège, Belgium.

Hela Jaidane (H)

Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives LR99ES27, Université de Monastir, 5000 Monastir, Tunisia.

Vincent Geenen (V)

GIGA-I3 Center of Immunoendocrinology, GIGA Research Institute, University of Liège, 4000 Liège, Belgium.

Didier Hober (D)

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, F-59000 Lille, France.

Classifications MeSH